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Protein trafﬁckingly requires extensive homomultimerization of the Gag polyprotein on cellular
membranes to generate the nascent particle bud. Here we generated a full-length, monomeric Gag
polyprotein bearing mutations that eliminated multimerization in living cells as indicated by ﬂuorescence
resonance energy transfer (FRET). Monomeric Gag resembled non-myristoylated Gag in its weak membrane
binding characteristics and lack of association with detergent-resistant membranes (DRMs or lipid rafts).
Monomeric Gag failed to assemble virus-like particles, but was inefﬁciently rescued into particles by
wildtype Gag through the inﬂuence of the matrix domain. The subcellular distribution of monomeric Gag
was remarkably different than either non-myristoylated Gag or wildtype Gag. Monomeric Gag was found on
intracellular membranes and at the plasma membrane, where it highlighted plasma membrane extensions
and rufﬂes. This study indicates that monomeric Gag can trafﬁc to assembly sites in the cell, where it
interacts weakly with membranes.
© 2009 Elsevier Inc. All rights reserved.Introduction
HIV-1 Pr55Gag (Gag) is a 55 kilodalton, myristoylated precursor
polyprotein that forms the structural core of the developing viral
particle. Gag is translated on cytoplasmic ribosomes, and subsequently
must translocate to the plasma membrane of cells for productive
assembly. Assembling particle buds appear by electron microscopy as
dense patches on the plasma membrane (Gelderblom, 1991), repre-
senting a focal site of homomultimerization of Gag on the cytoplasmic
face of the membrane. Plasma membrane curvature is elicited as
multimerizationprogresses, until a complete (or apparently complete)
spherical immature core has been formed. During or immediately
following particle budding, the viral protease cleaves Gag and core
maturation occurs, resulting in the formation of a conical viral core.
Three major Gag cleavage products are formed in this maturation
process; MA, CA, and NC, along two smaller peptides, SP1 and SP2.
Within the mature viral particle, the myristoylated, N-terminal MA
domain remains associatedwith the lipid envelope,while CA forms the
shell of the mature capsid and NC remains associated with the viral
RNA within the capsid structure.
Cryo-electronmicroscopic analysis of immature retroviral particles
has shown that Gag molecules are arranged in a radial fashion, with
the membrane binding MA domain in contact with the lipid envelope
and the C-terminal ends pointing toward the center of the particle
(Wilk et al., 2001). The Gag proteins of HIV, Rous sarcoma virus (RSV),man).
ll rights reserved.and murine leukemia virus (MLV) have each been shown to form a
spherical lattice composed of hexameric Gag rings (Briggs et al., 2004,
2006; Fuller et al., 1997; Wilk et al., 2001; Yeager et al., 1998). Lateral
Gag–Gag interactions within this lattice are critical to the formation
and stability of the immature virion core. Several crucial contact areas
between uncleaved Gag molecules have been identiﬁed. Biochemical
and mutagenesis studies support the presence of critical interactions
between Gag molecules in the C-terminal domain (CTD) of CA (Accola
et al., 2000; Borsetti et al., 1998; von Schwedler et al., 1998). Mutations
in key residues within the dimer interface of the CTD present in
mature capsids disrupt the production of immature particles,
suggesting that this interface is important in both structures (Datta
et al., 2007a; von Schwedler et al., 2003). N-terminal domain (NTD)
interactions have also been suggested to play a role within the
immature lattice (Lanman et al., 2003; von Schwedler et al., 2003).
Functional studies that preceded detailed structural studies revealed
an important contribution of NC to multimerization and assembly, a
contribution termed the “I” or interaction domain (Derdowski et al.,
2004; Parent et al., 1995; Sandefur et al., 1998, 2000; Weldon and
Wills, 1993). The functional contribution of NC to assembly is likely
due to its ability to bind nucleic acids, acting as a tether or nucleation
point for Gag–Gag multimerization (Campbell and Rein, 1999;
Campbell and Vogt, 1995). However, electron cryotomography has
revealed that the NC region is not highly ordered in immature
particles, while the CA NTD, CA CTD, and SP1 demonstrate clear
hexagonal order (Wright et al., 2007). This study demonstrated that
the CA and SP1 regions form a tightly-packed lattice of cup-shaped
hexamers (Wright et al., 2007). A model for Gag–Gag interactions in
immature particles is therefore becoming clearer, although deﬁning
Fig. 1. Emission scans representing FRET assay for the indicated pairs of Gag–CFP/YFP
constructs. SrcCANC (open circles) serves as a positive FRET control in both panels,
Myr(−) SrcCANC (triangles) as a negative control that illustrates a CFP curve. Total
YFP emission values are not shown in this ﬁgure but were measured separately, and
were of approximately equal intensity for each comparison. (A) SrcCANC(M39A/
W184A/M185A)NC15A pair fails to generate FRET (“X”). (B) Matrix and p6 regions do
not restore FRET to monomeric Gag (curve marked by “X”). Data were obtained on a
PTI scanning cuvette ﬂuorometer following excitation at 433 nm.
Fig. 2. Myristoylation of monomeric Gag constructs. (A) 3H-myristic acid labeling of
wildtype and monomeric Gag. Gag proteins were labeled for 8 h, then harvested and
immunoprecipitated with HIV patient sera and analyzed by SDS-PAGE and autoradio-
graphy. (B) A fraction of the lysates were analyzed by Western blotting using CA183
monoclonal antibody to demonstrate that all Gag proteins were produced in this
experiment.
342 J. Dou et al. / Virology 387 (2009) 341–352the precise contacts between Gag monomers in the hexameric lattice
of the immature particle will require additional, higher resolution
studies.
Multimerization of Gag may begin at intracellular sites distant
from the particle budding site. Distinct structural intermediates of
Gag have been described (Dooher and Lingappa, 2004; Lee and Yu,
1998; Morikawa et al., 1998, 2004) but remain to be ﬁrmly
established. Oligomers of Gag may exhibit distinct characteristics
contributing to particle assembly, such as distinct intracellular
trafﬁcking. To begin to approach this question, it would be useful
to fully characterize the Gag monomer. We recently reported the use
of a ﬂuorescence resonance energy transfer (FRET)-based assay in
living cells to deﬁne critical interfaces involved in assembly of the
immature HIV particle (Li et al., 2007). Surprisingly, myristoylation
was required for Gag–Gag interactions in this study, suggesting that
membrane interactions conferred by the myristoylated N-terminus of
MA are important for multimerization in cells. By combining amino
acid substitutions within the NTD and CTD of CA with extensive
substitution of basic residues in NC, we generated a myristoylated,
monomeric Gag molecule. Here we characterize a full-length,
myristoylated, monomeric Gag molecule expressed in mammalian
cells. The protein is unable to form particles, but can be rescued in an
inefﬁcient manner into particles in a manner dependent upon the
MA domain. Monomeric Gag is able to trafﬁc to the plasma
membrane, interacts weakly with cellular membranes, and exhibits
a subcellular distribution pattern that is markedly distinct from that
of wildtype Gag.Results
Characterization of a full-length monomeric Gag–CFP/YFP fusion protein
We previously used FRET to deﬁne domains and speciﬁc contacts
contributing to Gag–Gag multimerization (Li et al., 2007). Surprisingly,
multimerization was completely absent when paired Gag–CFP/YFP
constructs were expressed lacking N-terminal myristic acid. In the
context ofmyristoylated Gag–CFP/YFP, individual targeted substitutions
within the NTD (M39A) or CTD (W184A/M185A) diminished but did
not completely disrupt interaction. However, a combination of
substitutions in the NTD (M39A), CTD (W184A/185A), and NC
(NC15A, consisting of 15 substitutions of alanine for basic residues)
resulted in complete loss of FRET. In our previous study, the
substitutions were performed in the absence of MA and p6. In order
to determine if these regions contributed to Gag–Gag interactions, we
introduced these same substitutions into a full-length Gag protein
construct and analyzed its ability to multimerize along with a number
of controls.
The myristoylated Gag truncation construct SrcCANC demon-
strated a substantial amount of FRET, indicated by a strong peak
emission at 533 nm, while Myr(−) SrcCANC produced only a CFP
emission curve (Fig. 1A, compare open circles with open triangles).
Substitution of residues at the dimer interface alone (W184A/M185A)
in the context of SrcCANC resulted in diminished FRET, but did not
completely abolish Gag–Gag interactions (Fig. 1A open diamonds). In
contrast, introduction of additional NTD and NC substitutions [SrcCA
(M39A/W184A/M185A)NC15A] completely abolished FRET (Fig. 1A,
343J. Dou et al. / Virology 387 (2009) 341–352“X”). These results recapitulated our previous ﬁndings (Li et al., 2007),
and this construct will be referred to in this work as DMADP6
monomeric Gag. We next evaluated these same substitutions in the
context of a full-length Gag–CFP/Gag–YFP pair of constructs. The full-
length construct [MACA(M39A/W184A/M185A)NC15AP6] similarly
showed CFP ﬂuorescence but lacked a discernable FRET peak at
533 nm (Fig. 1B, “X”). These results indicated that MA and p6 did not
restore multimerization to the monomeric truncated protein. The full-
length, multiply-substituted construct will be referred to as full-
length monomeric Gag in this report. Note that in each case the YFP
ﬂuorescence of the YFP binding partner was similar in level of
expression as indicated by excitation at 513 and emission at 533 (data
not shown).
Myristic acid labeling of Gag constructs
Because lack of myristoylation had a dramatic effect in our FRET-
based multimerization assay, we wished to conﬁrm that the
monomeric Gag proteins were myristoylated. We labeled these and
control constructs with 3H-myristic acid and examinedmyristoylation
after immunoprecipitation of Gag from cell lysates. Fig. 2A shows that
wildtype Gag, monomeric Gag, and DMADP6 monomeric Gag were
each myristoylated. The labeling was speciﬁc, as myristoylation-
deﬁcient constructs failed to take up the label but were present on
Western blot (Figs. 1A and B). We conclude that the monomeric forms
of Gag described here were appropriately myristoylated.Fig. 3. Comparison of particle production by wildtype and monomeric Gag protein. (A) Wild
and supernatants were harvested at 24 h posttransfection, and the p24 antigen present in cel
as total p24 (left) and as percentage of particle release (right). (B) Pelleted supernatants wer
Note that monomer Gag was not detectable on the same scale as wildtype Gag (left panel, clo
particle density (1.138 g/ml, bottom gradient).Monomeric Gag is deﬁcient in formation of virus-like particles (VLPs)
Because Gagmust generate a lattice made of homomultimers in the
developing particle, it should not be possible for a monomeric Gag
molecule to form VLPs. In order to evaluate our candidate monomeric
Gag for particle formation, we compared the cellular and supernatant
p24 content after transfection of 293Tcellswithwildtype ormonomeric
Gag. At 36 h after transfection, cells and supernatants were harvested
and assessed for p24 antigen content. A signiﬁcant amount of particle
release was apparent fromwildtype but not monomeric Gag (Fig. 3A, S
lanes). The intracellular levels of Gag were higher for monomeric Gag,
consistent with a defect in particle production. A very small amount of
Gag was released into the supernatant by cells expressing monomeric
Gag, constituting just over 2% of the total Gag produced (Fig. 1A, right
panel). In order to determine if this inefﬁciently released Gag was
present in the form of VLPs, we analyzed the supernatants by pelleting
particulate material through a 20% sucrose cushion, followed by
equilibrium centrifugation on linear sucrose gradients. Wildtype Gag
attained a peak density of 1.155 g/ml (Fig. 3B). When performed in
parallel and plotted on the same scale, nomonomeric Gagwas apparent
at particle densities (Fig. 3B, left panel). However, a small amount of
light Gag was detected at a density of 1.138 g/ml (Fig. 3B, right panel,
note differences in scale on y-axis). The nature of the inefﬁciently
released, light Gag in this experiment is unclear. This density is not
dissimilar from microvesicle density, although the sharpness of the
peak would not be characteristic of microvesicles. We cannot rule outtype (open bars) and monomeric Gag (closed bars) were expressed in 293T cells. Cells
ls (C) or supernatants (S) was measured by antigen capture ELISA. Results are presented
e analyzed after equilibrium density centrifugation on linear 20–60% sucrose gradients.
sed vs. open circles). Using a different scale, a peak of p24 antigenwas detected at a low
344 J. Dou et al. / Virology 387 (2009) 341–352the possibility that very inefﬁcient formation of light particles may
occur through remaining weak Gag–Gag interactions not detected by
FRET. However, it seems more likely to us that a fraction of the
myristoylated monomer is exiting the cell in a membrane-bound form
other than a true VLP, perhaps through release of some of the plasma
membrane extensions induced upon expression of monomeric Gag
(discussed below).
Analysis of particle formation by transmission electron microscopy
In order to directly address the potential formation of particles
by monomeric Gag, we performed transmission electron micro-
scopic analysis of cells expressing this molecule and compared them
with those from wildtype Gag. HeLa cells were used in this analysis,
and cells were ﬁxed at 24 h after transfection. Protein levels on a
per-cell basis were similar in this experiment and in those reported
for 293T cells, although transfection efﬁciency was slightly lower in
HeLa (data not shown). At least two grids from each of three
separate experiments were analyzed. Immature particle formation
was easily detected in every case for wildtype Gag (Figs. 4A and B).
Despite scanning the majority of cell sections present on each grid
for particle formation, encompassing sections of several hundred
total cells, none was seen in cells expressing monomeric Gag
(representative cell shown in Figs. 4C and D). Notably, despite high
cellular concentrations of protein, we were unable to detect
intracellular particle formation by monomeric Gag. Some cells in
the sections from monomeric Gag-expressing cells exhibited long
cellular extensions (Fig. 4C), which may correlate with ﬁndings
presented below from ﬂuorescence microscopy.
Membrane binding is inefﬁcient, and detergent-resistant complexes are
not formed by monomeric Gag
Membrane binding of myristoylated monomeric Gag might be
expected to resemble binding of MA, which has low intrinsic afﬁnityFig. 4. Transmission electron microscopic analysis of particle production. (A) Wildtype Gag
power (A, bar=2.4mm) and higher magniﬁcation from the boxed region is shown below (B,
Shown is a representative cell, with prominent cell rufﬂes and ﬁlamentous extensions of thfor negatively-charged membranes as a monomer (Dalton et al.,
2007). To analyze the membrane binding of monomeric Gag, we
performed equilibrium ﬂotation centrifugation of cytosolic and
membrane components of lysed cells expressing wildtype Gag, Myr
(−) Gag, monomeric Gag, and DMADP6 monomeric Gag. In this
experiment, proteins were expressed with a C-terminal YFP tag and
Gag was quantiﬁed in each fraction by ﬂuorescence intensity.
Gradients were 50%/40%/10% step gradients of iodixanol as per-
formed previously (Ding et al., 2003). Wildtype Gag associated with
membranes efﬁciently, as evidenced by peak ﬂuorescence at the 40%/
10% interface (fraction 4, Fig. 5A). Myr(−) Gag also behaved as
expected, with predominantly cytosolic signal and a small amount of
membrane-bound protein. Both monomeric Gag proteins showed an
intermediate phenotype. The peak of Gag in the membrane layer
(fraction 4) was stronger than that for myr(−), but muchweaker than
wildtype Gag. We interpret these ﬁndings to mean that a lack of
multimerization does not allow cooperative effects that are necessary
for the efﬁcient membrane binding seen with the wildtype. Next, we
asked if monomeric forms of Gag can form detergent-resistant
complexes (DRCs). This assay involves treatment of cell lysates with
1% Triton X-100 at 4 °C, and is identical to that used by some
investigators to indicate lipid raft or “barge” association of Gag
(Lindwasser and Resh, 2001; Ono and Freed, 2001). Alternatively, Ono
et al. reported that iodixanol gradients (but not sucrose gradients)
allow the ﬂotation of detergent-resistant Gag multimers that are not
membrane-associated as indicated by resistance to octylglucoside
extraction (Ono et al., 2005). Wildtype Gag was present in the DRC
fraction, while myr(−) and both monomeric forms of Gag were
absent (Fig. 5B). We conclude that in this way monomeric Gag
resembles myr(−) Gag; it weakly associates with membranes and
cannot form DRCs. Note that the inability to form DRCs may indicate
the lack of formation of a “ﬂoatable” Gag multimer, consistent with
the ﬁndings of Ono et al. for iodixanol ﬂotation gradients, or in some
interpretations would indicate the inability of monomeric Gag to
associate with lipid rafts or detergent-resistant membranes.particles were easily detected in all ﬁelds; shown is one representative image at low
bar=305 nm). (C) No virus-like particles were seen in cells expressingmonomeric Gag.
e plasma membrane. Bar=3.2 mm in C, 750 nm in D.
Fig. 5. Membrane ﬂotation and detergent-resistant membrane formation. (A) Membrane ﬂotation in the absence of detergent. Cell lysates were layered onto the bottom of a 50%–40%–10% iodixanol gradient, and equilibrium ﬂotation
centrifugationwas carried out to separate membranes (40%–10% interface, fraction 4) from cytosol (fraction 10–12), using YFP ﬂuorescence as a marker of total Gag protein in the membrane or cytosol. (B) Flotation following treatment of cell
lysates with 1% TX-100 on ice for 30 min. Fraction 4 represents Gag–YFP on detergent-resistant membranes or putative rafts. Top of gradients is to the left.
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Fig. 7. Particle rescue experiments. A FLAG-tagged wildtype Gag protein was co-
expressed with HA-tagged Gag test constructs. Cell lysates and particles (pelleted
through sucrose) were evaluated by Western blotting with anti-FLAG or anti-HA
antibody. Top panel shows the wildtype Gag in cell lysates (left) and particles (right).
Bottom panel shows protein production in cell lysates (left); the right panel here
represents rescue of test constructs into particles by wildtype Gag. Blot shown is
representative of three independent experiments.
Fig. 6. FRET rescue experiments. The ability of wildtype Gag–CFP to interact with
(rescue) a series of test constructs expressed as YFP fusions was assessed by scanning
cuvette ﬂuorometry as described in Materials and methods. Wildtype Gag–YFP
(triangles) serves as positive control. (A) Myr(−) full-length monomeric Gag–YFP
and the indicated constructs were assessed for interactionwith Gag–CFP by FRET. (B)
Myr(+) full-length monomeric Gag–YFP and other indicated constructs were
assessed for interaction with wildtype Gag–CFP by FRET.
346 J. Dou et al. / Virology 387 (2009) 341–352Monomeric Gag is not rescued into complexes when co-expressed with
wildtype Gag
Myr(−) forms of Gag do not themselves form particles, but can be
rescued into particles when co-expressedwithwildtype,myristoylated
Gag. Thus, the ability to rescuemutatedGag into complexes or intoVLPs
can be used as a means of mapping Gag–Gag interactions (Burniston
et al.,1999). To determine if sufﬁcient capacity for interaction remained
in the monomeric Gag construct to support rescue, we co-expressed
wildtype Gag–CFP with a myr(−) version of monomeric Gag–YFP and
assessed for rescue of complexes by FRET. Fig. 6A shows that wildtype
Gag–CFP efﬁciently rescues myr(−) Gag–YFP, as indicated by the FRET
peak at 533 nm (open triangles). Myr(−) Gag–YFP proteins bearing
substitutions that had diminished but not negated FRET in the context
of a homologous pairing demonstrated an intermediate amount of
rescue (normalizing for CFPﬂuorescence). These includedGag proteins
bearing substitutions in CA but an intact NC [myr(−)CA(M39A/
W184A/M185A)NC and myr(−)CA(W184A/M185A)NC]. Myr(−)
monomeric Gag (open diamonds) and Myr(−) DMADP6 monomeric
Gag were not rescued into functional FRET pairs when co-expressed
with wildtype Gag–CFP. These results support the conclusion that CA–
CA interactions andNC–RNA interactionswere sufﬁciently disrupted bythe substitutions in both monomeric constructs to prevent interaction
and rescue by the wildtype molecule.
We then asked if the Myr(+) monomeric Gag construct could be
rescued into a FRET pair by Myr(−) wildtype Gag. Fig. 6B includes
Myr(−) WT Gag as a positive control as before (open triangles).
Gag–CFP again failed to rescue Myr(−) monomeric Gag–YFP into a
FRET pair (open diamonds). Similarly, myristoylated monomeric Gag
was not rescued by wildtype Gag–CFP (closed circles). Thus the
substitutions introduced in CA and NC were sufﬁcient to disrupt
Gag–Gag interactions even in the context of the myristoylated pairs.
Monomeric Gag is inefﬁciently incorporated into wildtype particles;
role of the MA domain
Another assay for rescue of assembly-deﬁcient Gag molecules is
represented by the appearance of particle-deﬁcient forms of Gag in
the supernatant upon expression of the wildtype protein. We used
wildtype Gag bearing a C-terminal FLAG epitope as the particle-
competent rescue vehicle, and expressed particle-deﬁcient forms of
Gag bearing a C-terminal HA epitope. The upper blot in Fig. 7 was
probed with anti-FLAG antibody. Note that for each lane where Gag–
FLAG was expressed in the cell, a corresponding Gag band was
detected in the pelleted supernatant fraction (Fig. 7, top). Proteins to
be rescued are shown by anti-HA blotting in Fig. 7. Test constructs
were approximately equally expressed in cells (Cell, lanes 1–7).
Myr(−) wildtype Gag, full-length monomeric Gag, and myr(−)
monomeric Gag each failed to form viral particles when expressed
alone (Fig. 6B, supernatant lanes 9, 10, and 11, respectively).
347J. Dou et al. / Virology 387 (2009) 341–352Expression of wildtype Gag with myr(−) Gag efﬁciently rescued this
protein into particles (lane 12). Myristoylated, monomer Gag was also
rescued into particles, albeit with reduced efﬁciency (lane 13). Myr
(−) monomeric Gag was found in particles minimally (Fig. 7, see faint
band in lane 14). The difference between rescue of myr(−) wildtype
Gag and myr(−) monomeric Gag supports the idea that monomeric
Gag is indeed unable to multimerize and be rescued (compare lanes
12 and 14). However, it is less clear what the partial rescue of the
myristoylated monomer indicates. We speculate that the monomer is
able to reach a common site of assembly at the plasma membrane
through its myristoylated N-terminus, where it may be passively
incorporated into the developing particle bud formed by thewildtype.
This contention will be discussed in the section describing the
subcellular localization of monomeric Gag later in this report.
To further investigate the requirements for the partial rescue
described above, we asked whether MA was required. MA contains
essential membrane binding and targeting functions for Gag, so it
would be a reasonable hypothesis that MA may be required for
monomeric Gag to reach the particle assembly site. MA–MA inter-
actions or MA–RNA interactions could also contribute, although these
were clearly not sufﬁcient for multimerization as measured by FRET.
We therefore repeated the particle rescue experiment with FLAG-
tagged wildtype Gag and assembly-incompetent HA-tagged mutants,
and included in this experiment monomeric Gag lacking MA (DMA
monomeric Gag, faster migrating band in lanes 4 and 7, Fig. 8). Note
that the DMA construct includes the v-srcmyristoylation signal at the
N-terminus. Myristoylated, monomeric Gag was again rescued
inefﬁciently by wildtype Gag (Fig. 8, lane 13). No rescue of DMA
monomeric Gag was seen (lane 14). These results suggest that the MA
region in the full-length monomer Gag contributed to the incompleteFig. 8. Role of MA in particle rescue. FLAG-tagged wildtype Gag was co-expressed with
HA-tagged Gag test constructs as in Fig. 7. Inefﬁcient but real rescue of the
myristoylated, monomeric Gag is demonstrated in particle blot, while DMAmonomeric
Gag (faster migrating band, lanes 4 and 7) was not rescued (lane 14). Blot shown is
representative of three independent experiments.rescue of monomeric Gag. This effect could be a result of intracellular
targeting to the particle assembly site, or potentially through MA–MA
or MA–nucleic acid interactions.
Monomeric Gag exhibits a unique intracellular distribution
One of the valuable features of studying amonomeric Gag protein is
its potential to illuminate steps in the intracellular trafﬁcking of Gag.
Fluorescence confocal microscopy was performed to deﬁne the
subcellular distribution of monomeric Gag vs. that of wildtype Gag.
MonomericGagwasﬁrst expressed inHeLa cells and stainedwith anti-
MA polyclonal antisera or as an HA-tagged protein detected with anti-
HA polyclonal sera. For comparison, wildtype Gag was examined in
parallel using the same techniques, cells, and antisera. Monomeric Gag
staining was found to be present throughout the cytoplasm, but was
clearly accentuated on intracellular membranes, and lacked any bright
puncta (Figs. 9A, G, and J). The intracellular pattern was membranous
and somewhat reticular. The plasma membrane accentuation and
reticular pattern contrasted signiﬁcantly with non-myristoylated Gag,
which was more diffusely distributed and did not mark the plasma
membrane (Fig. 9B vs. A). The intracellular reticular pattern was
somewhat suggestive of association with ER membranes to us;
however we found little overlap when using a speciﬁc ER label (Fig.
9D, green is ER). Monomeric Gag tagged with HA (panel A) and
untagged monomeric Gag (not shown) were essentially identical in
distribution. In addition, the proteinwas clearly present in a thin layer
underlying the plasma membrane. Remarkably, monomeric Gag but
not wildtype Gag revealed long, thin extensions of the plasma
membrane as well as prominent membrane rufﬂing (Figs. 9A, D, G,
J). These extensions were consistently seen in cells that were not
retracted, andwere suggestive to us of the induction of true rufﬂes and
cellular extensions rather than ﬁxation artifacts. A careful analysis of
wildtype Gag was performed in parallel, using identical ﬁxation and
staining techniques. Although this seemed to indicate that monomeric
Gag induces membrane extensions, normal HeLa cells exhibited
similar cellular extensions (data not shown), suggesting instead that
wildtype Gag caused their loss. Live cell imaging conﬁrmed the
formation of long cellular extensions in the absence of any ﬁxation
(data not shown). The use of a palmitoylated membrane marker
(ECFP-MEM) accentuated the colocalization of monomeric Gag and
notwildtype Gag onmembrane extensions (Fig. 9E vs. F). In contrast to
monomeric Gag, bright puncta were apparent in the majority of cells
expressing wildtype Gag (Fig. 9C). While punctawere easily discerned
inside of cells, small puncta on the plasmamembrane and surrounding
cells, corresponding to particles seen by electron microscopy in Fig. 4,
were also noted. However, the distinction in subcellular distribution
betweenmonomeric Gag andwildtype Gag may be better appreciated
when both are expressed together with distinct tags. To compare
wildtype and monomeric Gag in the same cell, we cotransfected HA-
tagged monomeric Gag and FLAG-tagged wildtype Gag, and stained
speciﬁcally with antibodies directed against each tag. Figs. 9G–I and
Figs. 9J–L demonstrate the distinct patterns of the two proteins, with
wildtype in red and monomeric Gag in green. Notably, expression of
wildtype Gag revealed much more intracellular, punctate staining.
Wildtype Gag did not appear to redistribute monomeric Gag
extensively into Gag puncta, as the pattern of intracellular and plasma
membrane staining was quite similar for monomeric Gag in the
absence (Figs. 9A and B) or presence (Figs. 9D and G) of wildtype Gag.
However, there were a few intracellular puncta that were brightly
stained for wildtype and less intense but present for monomeric Gag,
indicating speciﬁc colocalization/concentration at these intracellular
sites. These are illustrated by the puncta near the asterisks in Figs. 9G
and H. These colocalized puncta may represent the formation of
intracellular vesicles where the molecules are co-recruited. An
alternative explanation is that wildtype Gag particles are endocytosed
from the plasma membrane as reported (Jouvenet et al., 2006),
Fig. 9. Subcellular distribution of monomeric Gag differs markedly from wildtype. Cells expressing Gag constructs were ﬁxed and stained with anti-Gag or with antibodies
against epitope tags and examined by confocal ﬂuorescence microscopy. (A) Monomeric Gag–HA stained with anti-HA antisera. (B) Non-myristoylated, untagged Gag stained
with anti-MA antisera. (C) Wildtype Gag stained with anti-p24 monoclonal antibody. (D) Monomer Gag is shown in red in this panel, and endoplasmic reticulum staining in
green. (E) pECFP-MEM is shown in blue, marking the plasma membrane, and monomer Gag in red. Areas of light blue/white signal indicate colocalization. (F) Wildtype Gag
stained with anti-MA antibody is shown in red, and pECFP-MEM in blue. (G–I) Coexpression of monomeric Gag–HA and wildtype Gag–FLAG. Monomeric Gag–HA is shown in
green (G and I). Wildtype Gag–FLAG is shown in red (H and I). (K–L) Coexpression of monomeric Gag–HA and wildtype Gag–FLAG, same technique as in (G–I). Size bars
indicate 16 mm in each panel.
348 J. Dou et al. / Virology 387 (2009) 341–352carrying along plasma membrane-associated monomeric Gag on the
other (inner) face of the plasma membrane to common intracellular
punctate sites. Together, these studies conﬁrmed the association of
monomeric Gagmolecules with intracellularmembranes andwith theplasma membrane, demonstrated a propensity of monomeric Gag to
highlight plasma membrane extensions and rufﬂes, and showed that
monomeric Gag itself is unable to form distinct plasma membrane or
intracellular puncta.
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Oligomerization of Gag is a central feature of retrovirus assembly.
In vitro models of assembly have provided a number of insights into
the process of Gag–Gag oligomerization. Formation of particles from
puriﬁed Gag protein in vitro can be stimulated by nucleic acids
(Campbell and Rein, 1999; Campbell and Vogt, 1995), and oligo-
nucleotides as short as 22 nucleotides promoted the assembly of Rous
sarcoma virus (RSV) particles (Ma and Vogt, 2002). This distance
represented twice the binding site size of a Gag monomer, suggesting
that formation of the Gag dimer is the critical nucleation step leading
to the polymerization of Gag. Recombinant, puriﬁed HIV Gag exists in
monomer–dimer equilibrium in solution, as elegantly shown by
sedimentation equilibrium measurements (Datta et al., 2007b).
Remarkably, interaction with the inositol phosphate IP6 converted
the equilibrium to monomer–trimer, suggesting that interaction
between MA and IP6 creates a trimer that may be the critical building
block for polymerization of Gag (Datta et al., 2007b). After the
formation of a critical small oligomer, higher-order oligomers must be
generated through lateral interactions in order to generate the
hexameric lattice that forms the developing shell of the immature
capsid. Details of how and where this process occurs within the cell
remain to be elucidated.
Studies of HIV assembly performed using recombinant protein in
vitro such as those described above have yielded a number of critical
insights into Gag–Gag interactions that are directly applicable to an
understanding of particle assembly in mammalian cells. The impor-
tance of the dimer interfacewithin the CA CTD, the role of the RNA–NC
interaction in catalyzing assembly, the ability of dimerizing leucine
zippers to replace the nucleic acid binding function of NC, among a
number of other ﬁndings, hold true both in cells and in vitro (Accola
et al., 2000; Campbell and Rein,1999; Campbell and Vogt,1995; Chang
et al., 2008; Gross et al., 1997; Guo and Liang, 2005; Li et al., 2007; von
Schwedler et al., 2003; Zhang et al., 1998). Examination of the
multimerization of Gag expressed in mammalian cells may also reveal
some differences, however. Gag expressed in cells is myristoylated,
and is translated in the complex environment of the cellular
cytoplasm. Cellular membranes are readily available for interactions
with the myristoylated N-terminus. We found previously that
myristoylation was crucial for Gag–Gag multimerization in cells, and
correlated with the occurrence of FRET signal on cellular membranes
(Li et al., 2007).While this requirement is not absolute, as indicated by
the formation of intracellular particles by myr(−) Gag in some high-
level expression systems (Gheysen et al., 1989), it may indicate a
requirement for interaction at the N-terminus of the molecule to elicit
efﬁcient assembly under normal conditions. One possibility is that Gag
simply concentrates on membranes through the membrane binding
motif in MA, and that upon concentration and nucleic acid tethering
by NC, higher-order multimerization proceeds. Another intriguing
possibility is that myristoylation results in formation of a trimeric
assembly intermediate, as recently suggested by the Rein group (Datta
et al., 2007b). They found that the interaction with inositol hexakis-
phosphate (IP6) in solution acts as a switch to induce extension of the
folded Gag molecule, suggesting that this conformational change may
be responsible for the change from monomer–dimer to monomer–
trimer equilibrium. In cells, if the trimer is the fundamental unit from
which polymerization of the Gag lattice proceeds, a myristoylated N-
terminus may replace the in vitro requirement for IP6 binding and
allow trimers to form.
By studying a monomeric Gag protein, we hope to gain insights
into early events in assembly. A number of important questions might
be asked using a monomeric Gag protein. For example, does Gagmove
as a monomer to the plasma membrane? Are domains involved in
interactions with host proteins functional in the monomer, or do they
require an oligomeric intermediate? This report describes our initial
characterization of the monomeric form of Gag that we had derivedfrom FRET-based studies in live cells. Monomeric Gag was unable to
form virus-like particles, at least that we could detect by electron
microscopy, and was released from the cell very inefﬁciently. Wild-
type Gag could not rescue monomeric Gag into complexes as judged
by FRET, and could not rescue the myr(−) monomer into particles.
Interestingly, although the monomeric, myristoylated Gag was
excluded from lipid rafts (using the biochemical fractionation criteria
of ﬂotation on detergent-resistant membranes (Ding et al., 2003;
Lindwasser and Resh, 2001; Ono and Freed, 2001), it must have
reached the same membrane microdomains from which wildtype
particles were budding in order to gain incorporation into particles.
The appearance of monomeric Gag at the plasma membrane suggests
that a multimeric intermediate is not absolutely required for transit to
the site of assembly. It remains possible, however, that an assembly
intermediate forms within the cell for speciﬁc trafﬁcking, and that the
kinetics or path of transit will differ between monomeric Gag and
wildtype Gag.
Rescue of the myristoylated, monomeric Gag into virus-like
particles by wildtype Gag required a contribution from MA. The
appearance of monomeric Gag at the plasma membrane by immuno-
ﬂuorescence analysis, together with the absence of FRET between
wildtype and monomer, suggests that this rescue may represent
passive incorporation at the particle assembly site, or that weak
interactions between MA domains may recruit monomeric protein
into particles but not allow direct interaction or the correct
positioning of the C-terminal ﬂuorescent proteins required to
generate a FRET signal. There are yet other potential explanations
for the contribution of MA to this rescue. A number of reports have
established an RNA binding role for MA (Burniston et al., 1999; Chang
et al., 2008; Cimarelli et al., 2000; Ott et al., 2005; Purohit et al., 2001),
and some have suggested that MA can partially compensate for the
loss of the RNA tethering role of NC (Burniston et al., 1999; Ott et al.,
2005). It is possible therefore that the incorporation of monomeric
Gag into wildtype particles was mediated by MA–RNA interactions. A
monomeric Gag molecule targeted to the cytoplasmic face of the
plasma membrane could interact with the RNA delivered there by
wildtype Gag and subsequently be incorporated into the particle,
without invoking direct protein–protein interaction. We favor the
explanation that the colocalization at particle assembly sites with
wildtype Gag allowed the monomeric protein to be incorporated
through weak MA–MA interactions. Additional studies will be
required to test this hypothesis.
The subcellular distribution of monomeric Gag was strikingly
different than that of wildtype Gag. Onemajor notable ﬁnding was the
lack of any particle puncta or any bright intracellular puncta. This is of
course not surprising for a monomeric Gag, as the bright puncta
represent multimers of Gag, either virus-like particles, developing
virus-like particles or multimers on intracellular membranes, or
endocytosed virus-like particles (Jouvenet et al., 2006; Larson et al.,
2005). The ﬁnding that monomeric Gag lines the plasma membrane,
and is somewhat concentrated on rufﬂes and on plasma membrane
extensions, suggests that some differential binding to the cytoplasmic
face of the plasma membrane may occur. A signiﬁcant fraction of
monomeric Gag also associates with intracellular membranes based
on imaging results. The interaction of monomeric Gag with mem-
branes is likely to be of low afﬁnity, even with myristic acid and the
positively-charged surface of MA available for interaction with the
membrane. Dalton et al. examined the contribution of myristic acid
to the afﬁnity of recombinant HIV MA for artiﬁcial membranes
(Dalton et al., 2007), and found that membrane binding was
increased by myristic acid but remained very weak. Dimerization
greatly enhanced membrane interactions in this in vitro system and
enhanced membrane binding in transfected cells (Dalton et al.,
2007). Monomeric Gag may not generate optimal exposure of
myristate, as Gag–Gag interactions provide conformational changes
that trigger the myristyl switch (Tang et al., 2004). Interaction with
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however, and we see no reason that the population of monomeric
Gag associated with the cytoplasmic face of the plasma membrane
should not be able to interact with PI(4,5)P2. Cooperative effects on
binding would clearly be present for oligomers and absent in the
monomer, and are likely to play a major role in stabilizing membrane
interactions of oligomeric forms of Gag.
This report establishes the monomeric nature of Gag bearing
M39A/W184A/M185A/NC15A mutations, and establishes its sub-
cellular localization in transfected cells. This monomeric Gag will be a
useful tool in further dissection of steps involved in HIV assembly. It
will be of interest to deﬁne the kinetics of movement of monomeric
Gag to the plasma membrane, and contrast this with movement of
wildtype Gag or Gag puncta. Further mutagenesis should clarify the
nature of the contribution of MA to incorporation of monomeric Gag
into wildtype virus-like particles. Ultimately it will be desirable to
trigger dimer or trimer linkages between monomers within live cells,
which should facilitate studies of the kinetics of assembly and
trafﬁcking of speciﬁc Gag multimers.
Materials and methods
Plasmid construction
The Gag coding sequences for all constructs were derived from the
codon-optimized HXB2 gag gene from plasmid pVRC3900 (Huang
et al., 2001). Gag proteins were initially cloned for expression as fusion
constructs with the cerulean variant of cyan ﬂuorescent protein (CFP)
(Rizzo et al., 2004) or the Venus variant of yellow ﬂuorescent protein
(YFP) (Nagai et al., 2002). CFP and YFP fusions were expressed at the
C-termini of Gag proteins produced in plasmid vectors pcDNA 4/TO
and pcDNA 5/TO (Invitrogen). Most of the YFP/CFP fusion constructs
in this study were described in our earlier work (Li et al., 2007). MACA
(M39A/W184A/M185A)NC15AP6-CFP was created from SrcCA
(M39A/W184A/M185A)NC15A-CFP using PCR mutagenesis to create
a full-length Gag–CFP with the indicated substitutions in vector
pcDNA4/TO. A YFP-tagged construct was created in an identical
fashion from SrcCA(M39A/W184A/M185A)NC15A-YFP. Untagged
MACA(M39A/W184A/M185A)NC15AP6 (monomeric Gag) was cre-
ated from MACA(M39A/W184A/M185A)NC15AP6-CFP by PCR clon-
ing of the Gag region as a HindIII–BamH1 fragment with the wildtype
stop codon introduced; this fragment was cloned into the same
pcDNA4/TO vector. Untagged DMADP6 monomeric Gag was created
from srcCA(M39A/W184A/M185A)NC15A-CFP by PCR cloning as a
HindIII–BamHI fragment, introducing a stop codon following the ﬁnal
codon of NC and ligating into the HindIII and BamH1 sites of pcDNA5/
TO. FLAG and HA fusions (WT Gag–FLAG-tagged, Myr(−) WT Gag–
HA, monomer Gag–HA, myr(−) monomer Gag–HA and DMA mono-
mer Gag–HA)were generated by PCR using HindIII sites at the 5′ end and
BamHI at the 3′ end, together with the coding sequence for the speciﬁc
tag on the 3′ oligo, and ligated into pcDNA 3.1+ (Invitrogen). Myr(−)
constructs included a G2A coding changewithin the 5′ oligo sequence. All
constructs were sequenced throughout the gag gene. Oligonucleotide
primers used for all PCR ampliﬁcations to generate constructs are
available upon request. pECFP-MEM expresses a palmitoylated form of
CFP and was obtained from Clontech.
Cells and transfections
293T cells were used for ﬂuorometer-based studies and for particle
production studies. HeLa cells were employed in EM and confocal
microscopic analysis. Cell lines were maintained in Dulbecco's
modiﬁed Eagle medium with 10% fetal bovine serum supplemented
with penicillin and streptomycin at 37 °C in 5% CO2. Transfections
were performed using the calcium phosphate transfection method or
via lipofection with Lipofectamine 2000 (Invitrogen).Scanning cuvette ﬂuorometry for FRET
Cells cotransfected with Gag–CFP and Gag–YFP constructs were
analyzed at 36 h posttransfection. Cells were washed with phosphate-
buffered saline (PBS) and thenharvested in PBS for analysis by scanning
ﬂuorometry. Cells in suspension or gradient fractions were analyzed by
scanning ﬂuorometry in a PTI T-format scanning cuvette spectro-
ﬂuorometer (Photon Technology International, Lawrenceville, NJ). For
FRET analysis, samples were excited at 433 nm, and an emission scan
range is from 460 nm to 550 nm. For the analysis of relative YFP
Fluorescence intensity, samples were excited at 513 nm, with a
resulting emission scan from 524 nm to 550 nm. Data were collected
from at least three independent experiments for each construct, and
the curves shown are representative of the three measures obtained.
Photomultiplier gain was adjusted slightly to normalize the CFP peak
intensity in each arm of the experiment in order to facilitate
comparison of the relative amounts of YFP (FRET) signal relative to CFP.
Isolation of cytosolic and membrane fractions
Cells were harvested for analysis 36 h following transfection. One
10 cm2 tissue culture dishof nearly conﬂuent293Tcellswasused in each
experimental sample. Cells were washed in NTE buffer (100 mM NaCl,
10mMTris–Cl [pH 8.0], 1mMEDTA [pH 8.0]) and then allowed to swell
in hypotonic buffer (10 mM Tris–Cl [pH 8.0], 1 mM EDTA [pH 8.0]) plus
protease inhibitors for 20min on ice. Cells were then broken by Dounce
homogenization. After the buffer was adjusted to 0.1 M NaCl, the nuclei
and unbroken cells were removed by centrifugation at 1000 ×g for
10 min. The supernatants containing cytosolic and membrane compo-
nents were then adjusted to 50% iodixanol from a stock solution of 60%
iodixanol (Nycomed Pharma, Oslo, Norway), and 40% and 10% solutions
of iodixanol were layered sequentially on top. The preparationwas then
centrifuged in a Beckman SW41 rotor at 41,000 rpm for 2 h at 4 °C, after
which 12 fractions were harvested from the top of the gradient (from
fraction 1 to fraction 12); and then all the fractions were analyzed by
cuvette ﬂuorometry. For analysis of detergent-resistant membranes,
postnuclear cellular fractions were treated wit 1% TX-100 on ice for
30 min prior to the fractionation procedure.
Sucrose gradient sedimentation
Supernatants were harvested 36 h after transfection with the
indicated Gag protein expression plasmids. Cells and debris in
supernatants were removed by centrifugation at 1000 ×g for
10 min, followed by ﬁltration through 0.45 μm syringe driven ﬁlter
unit (Millipore). Particles were then concentrated and puriﬁed by
pelleting through a 20% sucrose cushion in a Beckman SW32 rotor at
30,000 rpm for 2 h at 4 °C. Particle pellets were resuspended in
phosphate-buffered saline (PBS), and were subjected to equilibrium
gradient centrifugation on a 20–60% linear sucrose gradient in an SW-
41 rotor at 35,000 rpm for 12–14 h at 4 °C. 12 fractions were harvested
from the top of the gradient (from fraction 1 to fraction 12) and then
all the fractions were analyzed by cuvette ﬂuorometry and refractive
index, from which the density of each fraction was calculated.
Myristic acid labeling
Myristic acid incorporation was examined using Gag expression in
293T cells. Complete culture medium was replaced by Dulbecco's
Modiﬁed Eagle Medium containing 5% delipidated fetal calf serum for
30min, followed by incubation in the samemedia supplementedwith
50 μCi of 3H-myristic acid per milliliter (55 Ci/mmol; Amersham). The
cells were incubated for an additional 8 h, and then Gag proteins were
immunoprecipitated with HIV patient sera and analyzed by SDS-PAGE
and autoradiography. Western blotting of a fraction of the same cells
was performed to analyze the total Gag population.
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Transfected 293T cells or particle pellets were harvested 36 h
posttransfection. Cells were lysed in radioimmunoprecipitation assay
buffer (25 mM Tris–HCl [pH 7.6], 150 mM NaCl, 1% NP-40, 1% sodium
deoxycholate, 0.1% sodium dodecyl sulfate). Particles were pelleted
through 20% sucrose as described above, and resuspended in SDS-PAGE
load buffer. Cells and supernatants were examined byWestern blotting
using anti-green ﬂuorescent protein rabbit serum (Invitrogen), rabbit
anti-FLAG antibody (OctA-Probe) (Santa Cruz Biotechnology), mouse
HA.11 Monoclonal Antibody (Covance) as the primary antibody and
goat anti-rabbit (IRDye800; Li-Cor Biosciences) or goat anti-mouse
(IRDye680; Li-Cor Biosciences) as the secondary antibody. Blots were
imaged using infraredﬂuorescence detection using theOdyssey system
(Li-Cor Biosciences).
Laser confocal ﬂuorescence microscopy
HeLa cells were grown on glass coverslips and transfected with the
indicated Gag or monomeric Gag expression constructs, or with Gag–
FLAG and monomeric Gag–HA. Cells were washed and ﬁxed after 18 h
posttransfection with 4% paraformaldehyde solution (Electron Micro-
scopy Sciences) for 10 min. Primary antibodies for detection were
rabbit anti-MA polyclonal (Varthakavi et al., 1999), anti-p24 mono-
clonal CA-183 (provided by Bruce Chesebro and Kathy Wehrly
through the NIH AIDS Research and Reference Reagent Program),
anti-FLAG F3165 (Sigma) or rabbit anti-HA H6908 (Sigma). ER
staining was performed using the Alexa Fluor 488 endoplasmic
reticulum staining kit from Invitrogen. Images were obtained using a
spinning disk confocal microscope from Improvision (now part of
Perkin-Elmer); each ﬁeldwas imaged using a 63× oil objectivewith an
NA of 1.4. Images were analyzed using the Volocity software package
(Improvision/Perkin-Elmer).
Electron microscopy
Transfected 293Tcells were ﬁxed in 3% gluteraldehyde in cacodylate
buffer. Dehydration, embedding, staining, and ultramicrotomy were
performed for analysis by transmission EM as described before (Dong
et al., 2005). Thin sections were analyzed on a Hitachi H-7500 trans-
mission electron microscope.
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